-
Mashup Score: 2Can AI Help Increase Time for Patient Care? - 3 month(s) ago
More than two-thirds of physicians say that AI has helped increase time for patient care by reducing administrative workload, or that it can in the…
Source: opmed.doximity.comCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 0Implicit Bias: The Human Phenomenon That AI Could Buffer Against - 3 month(s) ago
“When did your pain start?” I asked. The patient, a petite middle-aged man, did not appear to hear my question. He moaned, clearly uncomfortable. “…
Source: opmed.doximity.comCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 0How Can Physicians Drive Health Care Innovation? - 3 month(s) ago
John R. Dayton, MD is an emergency medicine physician with Intermountain Health in Utah. He was the first Medical Innovation Fellow with Stanford’s…
Source: opmed.doximity.comCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 0Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia | NEJM - 4 month(s) ago
Original Article from The New England Journal of Medicine — Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia
Source: www.nejm.orgCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 19
As the editorial by Dr Aster 1 points out, there are various differences between the WHO and International Consensus Classification (ICC) classifications of hematolymphoid tumors. However, these are relatively few and calling this a schism is an overstatement of the facts. It can be argued that many of these differences simply reflect areas of uncertainty where evidence is currently insufficient or arbitrary thresholds are applied by different groups around the world, rather than there being fundamentally
Source: ascopubs.orgCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 6Unleashing the Spark: My Top #ASH23 Posts That Ignited Engagement - 5 month(s) ago
Twitter proved my secret weapon for connecting with fellow hematology/oncology minds at the American Society of Hematology (ASH) annual meeting thi…
Source: opmed.doximity.comCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 19
As the editorial by Dr Aster 1 points out, there are various differences between the WHO and International Consensus Classification (ICC) classifications of hematolymphoid tumors. However, these are relatively few and calling this a schism is an overstatement of the facts. It can be argued that many of these differences simply reflect areas of uncertainty where evidence is currently insufficient or arbitrary thresholds are applied by different groups around the world, rather than there being fundamentally
Source: ascopubs.orgCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 3Shibboleth Authentication Request - 5 month(s) ago
If your browser does not continue automatically, click
Source: login.moffitt.idm.oclc.orgCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 6
Program: Oral and Poster Abstracts Type: Oral Session: 624. Hodgkin Lymphomas and T/NK Cell Lymphomas: Clinical and Epidemiological: Advances in Treating T Cell Lymphomas Hematology Disease Topics & Pathways: Research, clinical trials, Lymphomas, Clinical Research, T Cell lymphoma, Diseases, Lymphoid Malignancies Steven M. Horwitz, MD 1, Koji Izutsu, MD, PhD 2, Neha Mehta-Shah, MD 3, Raul Cordoba, MD, PhD 4, Stefan K. Barta, MD, MRCP, MS 5 *, Emmanuel Bachy, MD, PhD 6 *, Giuseppe Gritti 7 *, Eric Jacobsen,
Source: ash.confex.comCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 8Paper: Mosunetuzumab Monotherapy Demonstrates Activity and a Manageable Safety Profile in Patients with Relapsed or Refractory Richter’s Transformation - 5 month(s) ago
Program: Oral and Poster Abstracts Type: Oral Session: 627. Aggressive Lymphomas: Clinical and Epidemiological: Aiming for the Right Target: Using CAR-T and Bispecifics in Aggressive Lymphomas Chan Y. Cheah, MBBS 1,2, Sarit Assouline, MD 3, Ross Baker, MBBS 4 *, Nancy L. Bartlett, MD 5, Dima El-Sharkawi, MBBS, FRCPath, PhD 6 *, Pratyush Giri, MBBS 7 *, Matthew Ku, MBBS 8 *, Stephen J. Schuster, MD 9, Matthew Matasar, MD, MS 10, John Radford, MD 11 *, Michael C. Wei, MD, PhD 12 *, Shen Yin, PhD 12 *, Iris
Source: ash.confex.comCategories: General Medicine News, Hematologists1Tweet
How different specialists see AI https://t.co/RT7EilCLaK